The Latin America, Middle East and Africa Forensic Genomics Market should witness market growth of 16.7% CAGR during the forecast period (2022-2028).
Genome sequencing is important because genomics can identify many generic variants that are more likely to cause disease in asymptomatic individuals. This is useful for finding recently identified antibacterial chemicals to prevent the spread of bacterial infections. Gene therapy is used to treat many ailments in place of conventional medications and operations.
But genomics is not restricted to the healthcare system. It is employed in pharmacogenomics, forensics, agriculture, and the study of human ancestry. The ability to forecast community behavior in various situations and efficient and cost-effective genetic testing of various diseases are fueling the market growth. Numerous portable equipment varieties have been created for in-depth investigation in the field.
Unstable, perishable, or toxic substances are transported to the laboratory using portable forensic instruments. A DNA sample is also sequenced by experts, who then give detectives details about potential suspect traits including eye, hair, and skin color. Utilizing more recent techniques, biological and age backgrounds may also be predicted. In order to identify the suspect, the staff can also employ biosensors to examine the minuscule amounts of biological fluids found in fingerprints.
The Costa Rican government passed a novel paternity law known as Law 8101 Ley de Paternidad Responsable. According to reports, the bill is the first of its sort in Latin America as well as in the entire world. According to the law, a mother may, after going through an administrative process, reveal the identity of the child's father. After which the concerned man is instructed to take a DNA test. If the male declines to take the test, he is automatically deemed to be the kid's father by the law and is required to pay child support.
The Brazil market dominated the LAMEA Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $14.4 Million by 2028. The Argentina market is exhibiting a CAGR of 17.3% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 16.3% during (2022-2028).
Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.
Genome sequencing is important because genomics can identify many generic variants that are more likely to cause disease in asymptomatic individuals. This is useful for finding recently identified antibacterial chemicals to prevent the spread of bacterial infections. Gene therapy is used to treat many ailments in place of conventional medications and operations.
But genomics is not restricted to the healthcare system. It is employed in pharmacogenomics, forensics, agriculture, and the study of human ancestry. The ability to forecast community behavior in various situations and efficient and cost-effective genetic testing of various diseases are fueling the market growth. Numerous portable equipment varieties have been created for in-depth investigation in the field.
Unstable, perishable, or toxic substances are transported to the laboratory using portable forensic instruments. A DNA sample is also sequenced by experts, who then give detectives details about potential suspect traits including eye, hair, and skin color. Utilizing more recent techniques, biological and age backgrounds may also be predicted. In order to identify the suspect, the staff can also employ biosensors to examine the minuscule amounts of biological fluids found in fingerprints.
The Costa Rican government passed a novel paternity law known as Law 8101 Ley de Paternidad Responsable. According to reports, the bill is the first of its sort in Latin America as well as in the entire world. According to the law, a mother may, after going through an administrative process, reveal the identity of the child's father. After which the concerned man is instructed to take a DNA test. If the male declines to take the test, he is automatically deemed to be the kid's father by the law and is required to pay child support.
The Brazil market dominated the LAMEA Forensic Genomics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $14.4 Million by 2028. The Argentina market is exhibiting a CAGR of 17.3% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 16.3% during (2022-2028).
Based on Application, the market is segmented into Criminal Testing, Paternity & Familial Testing and Others. Based on Product, the market is segmented into Kits & Consumables, Analyzers & Sequencers and Software. Based on Method, the market is segmented into Capillary Electrophoresis, Next-generation Sequencing and PCR Amplification. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Eurofins Scientific Group (Eurofins Discovery), Gene by Gene, Ltd., Verogen, Inc., Agilent Technologies, Inc., Illumina, Inc., Neogen Corporation, and Thermo Fisher Scientific, Inc.
Scope of the Study
By Application
- Criminal Testing
- Paternity & Familial Testing
- Others
By Product
- Kits & Consumables
- Analyzers & Sequencers
- Software
By Method
- Capillary Electrophoresis
- Next-generation Sequencing
- PCR Amplification
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co. (GE Healthcare)
- Eurofins Scientific Group (Eurofins Discovery)
- Gene by Gene, Ltd.
- Verogen, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Neogen Corporation
- Thermo Fisher Scientific, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Forensic Genomics Market by Application
Chapter 5. LAMEA Forensic Genomics Market by Product
Chapter 6. LAMEA Forensic Genomics Market by Method
Chapter 7. LAMEA Forensic Genomics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- General Electric (GE) Co. (GE Healthcare)
- Eurofins Scientific Group (Eurofins Discovery)
- Gene by Gene, Ltd.
- Verogen, Inc.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Neogen Corporation
- Thermo Fisher Scientific, Inc.
Methodology
LOADING...
